News
![Is Cigna Group the Nation's Best-Run Health Insurance Company?: https://www.marketbeat.com/logos/articles/med_20240525153829_chart-ci.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNFdtYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--68d13e950e219caf7e551b20d51067899d3c79ca/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20240525153829_chart-ci.jpg?locale=us)
Is Cigna Group the Nation's Best-Run Health Insurance Company?
Health insurance companies in the medical sector have not fared well in 2024. Medicare Advantage (MA) plans were a bountiful source of income until the second half of 2023. Humana Inc. (NYSE: HUM)
![2 Stocks Providing Medical Insurance for Your Pets: https://www.marketbeat.com/logos/articles/med_20240519155501_chart-trup.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBL0dmYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--0361f7ce61ed24b18fdb29c8f59dfe9afabfc514/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20240519155501_chart-trup.jpg?locale=us)
2 Stocks Providing Medical Insurance for Your Pets
The pandemic triggered a surge in pet ownership as social distancing and lockdowns resulted in the need for companionship for many individuals and families. Anyone who owns a dog or cat can
![CVS Health Stock Has a Silver Lining Called Value: https://www.marketbeat.com/logos/articles/med_20240519153028_chartzy-cvs.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNVNlYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--7eec854770c4c9d9d0c4acb291fbda148767fdde/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20240519153028_chartzy-cvs.jpg?locale=us)
CVS Health Stock Has a Silver Lining Called Value
Integrated healthcare retailer and insurer CVS Health Co. (NYSE: CVS) stock presents a value not seen in years. The medical sector giant saw its shares punished on its Q1 2024 top and bottom line
![Undervalued UnitedHealth Group Won’t Be For Long: https://www.marketbeat.com/logos/articles/med_20240416091545_chart-unh-4162024ver001.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNlYyYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--37a74b1a3fcab0bdc0142212ea4943d3985da28e/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20240416091545_chart-unh-4162024ver001.png?locale=us)
Undervalued UnitedHealth Group Won’t Be For Long
UnitedHealth Group's (NYSE: UNH) Q1 results were better than expected for two reasons: First, the stock price is now rebounding from long-term lows and deep value territory with ample upside
![Novo Nordisk Arms Wegovy to Be a Triple Threat: https://www.marketbeat.com/logos/articles/med_20240414165029_charts-nvo.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBN3AwYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--e47c7933e52c31d10e1f1c7064b6363cad48200b/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20240414165029_charts-nvo.jpg?locale=us)
Novo Nordisk Arms Wegovy to Be a Triple Threat
Ozempic usage for weight loss has gone viral, making it the highest revenue-generating drug for Novo Nordisk AV/S (NYSE: NVO). Originally purposed for Type 2 diabetes, the skyrocketing off-label
![DexCom Stock Gains from GLP-1 Diabetic Users: https://www.marketbeat.com/logos/articles/med_20240331131923_chart-dxcm.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNjVuYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--ed9b4f6128e9df807efa84690aadbaeebea9fd06/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20240331131923_chart-dxcm.jpg?locale=us)
DexCom Stock Gains from GLP-1 Diabetic Users
DexCom Inc. (NASDAQ: DXCM) is a leading medical device company in the medical sector that specializes in continuous glucose monitoring (CGM) systems. People with diabetes use CGM systems to
![Is UnitedHealth Group Stock a Strong Buy or a Falling Knife?: https://www.marketbeat.com/logos/articles/med_20240304134833_is-unitedhealth-group-stock-a-strong-buy-or-a-fall.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBMEpLYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--8c18da84eeaeb30f1ea4ac50293355fb02bd34d0/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20240304134833_is-unitedhealth-group-stock-a-strong-buy-or-a-fall.jpg?locale=us)
Is UnitedHealth Group Stock a Strong Buy or a Falling Knife?
UnitedHealth Group Inc. (NYSE: UNH) has given up almost all of its 12-month gains in the last week after two unrelated incidents have rocked the company. At the close of trading on March 1, 2024
![Can UnitedHealth Group afford to keep Medicare Advantage plans?: https://www.marketbeat.com/logos/articles/med_20240218165851_can-unitedhealth-group-afford-to-keep-medicare-adv.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBeHMzYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--9daa919fb7df908639c9904a9681a2cd6724ae14/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20240218165851_can-unitedhealth-group-afford-to-keep-medicare-adv.jpg?locale=us)
Can UnitedHealth Group afford to keep Medicare Advantage plans?
Medicare Advantage plans have been making headlines in 2024, but not in a positive light, at least for health insurance companies. Medicare is a government-sponsored health insurance benefit
![Why Cigna stock will be at fresh highs by March: https://www.marketbeat.com/logos/articles/med_20240207143124_why-cigna-stock-will-be-at-fresh-highs-by-march.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBeGtzYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--908bda838dab724b60517c1ec47b43e11896b4bd/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20240207143124_why-cigna-stock-will-be-at-fresh-highs-by-march.jpg?locale=us)
Why Cigna stock will be at fresh highs by March
The Cigna Group’s (NYSE: CI) 35% rally that started last summer just hit a new high gear. While investors would have been spooked by the 20% slide from November into December, all that damage has
![Is Humana’s pain HCA Healthcare’s gain?: https://www.marketbeat.com/logos/articles/med_20240204124713_chart-hca2.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBN1FvYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--d64343d6b4142cf3efbcbee04dd36f11cdc6cdd2/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20240204124713_chart-hca2.jpg?locale=us)
Is Humana’s pain HCA Healthcare’s gain?
HCA Healthcare Inc. (NYSE: HCA) is the largest for-profit hospital company in the United States. The company owns and operates 186 hospitals and nearly 2,400 ambulatory sites, including
![Med-tech stock Conmed dips ahead of big Q4 report...opportunity?: https://www.marketbeat.com/logos/articles/med_20240129182456_med-tech-stock-conmed-dips-ahead-of-big-q4-report.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBM3dpYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--7914ce1ca5d7c5e02f1ec21fcc71a343e08d98b5/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20240129182456_med-tech-stock-conmed-dips-ahead-of-big-q4-report.jpg?locale=us)
Med-tech stock Conmed dips ahead of big Q4 report...opportunity?
When Utica, NY-based medical technology company CONMED Corporation (NYSE:CNMD) reports fourth quarter financials after the close on Wednesday, it is expected to post some of its best growth in
![4 med tech stocks with improving prognosis for 2024: https://www.marketbeat.com/logos/articles/med_20240130110415_chart-jnj-1302024ver001.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBM3NpYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--2c5e4cd8e187d6698e73b1d079fa2a0bfd1f9f76/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20240130110415_chart-jnj-1302024ver001.png?locale=us)
4 med tech stocks with improving prognosis for 2024
Med tech stocks have been a mixed bag of results the last two years, with most moving within established trading ranges. The impact of COVID and its effect on procedure volumes were slow to
![Humana EPS shocker. Are Medicare Advantage plans in jeopardy?: https://www.marketbeat.com/logos/articles/med_20240129150334_humana-eps-shocker.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNDBkYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--ccb1572d67e87344b9595fe39d3a5f0bdb4509fb/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20240129150334_humana-eps-shocker.jpg?locale=us)
Humana EPS shocker. Are Medicare Advantage plans in jeopardy?
Health insurance carrier Humana Inc. (NYSE: HUM) reported a bombshell when it released its fourth-quarter 2023 earnings report. The company not only missed its estimated EPS by a mile but also
![5 top healthcare stocks for earnings growth in 2024: https://www.marketbeat.com/logos/articles/med_20240124120518_5-top-healthcare-stocks-for-earnings-growth-in-202.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBLzRXYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--603b6f3363f5b803bb05f2ff2c902c3d9e326b9c/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20240124120518_5-top-healthcare-stocks-for-earnings-growth-in-202.jpg?locale=us)
5 top healthcare stocks for earnings growth in 2024
While the healthcare sector delivered lackluster profit growth in 2023, it should change this year.
Sector components forecast to show the biggest earnings year-over-year earnings improvement
![UnitedHealth's rising premiums could cushion stubborn inflation: https://www.marketbeat.com/logos/articles/med_20240116085908_unitedhealths-rising-premiums-could-cushion-stubbo.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBeU1PYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--1561fd64097f32595182e80f94c532b578cff459/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20240116085908_unitedhealths-rising-premiums-could-cushion-stubbo.jpg?locale=us)
UnitedHealth's rising premiums could cushion stubborn inflation
When markets become uncertain about the economy's direction and stocks trend in a bumpy and indecisive pattern, some sectors usually attract investment dollars because of their perceived safety.
![Time to buy these 3 healthcare companies that raised revenue guidance?: https://www.marketbeat.com/logos/articles/med_20240114165541_chart-exas2.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBLzRNYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--6f6726c0f30bff53e31503bb77e9bbadba446018/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20240114165541_chart-exas2.jpg?locale=us)
Time to buy these 3 healthcare companies that raised revenue guidance?
The new year brings a clean slate heading into the fourth-quarter earnings season. Companies can usually gauge if their previous forecasts were in line or need to be adjusted to warn or prepare
![UnitedHealth Group Looks Buyable After AI-Fueled Double Beat: https://www.marketbeat.com/logos/articles/med_20240112120135_unitedhealth-group-looks-buyable-after-ai-fueled-d.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBendLYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--957529a16a5c614d0e4510560914575f9cd47758/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20240112120135_unitedhealth-group-looks-buyable-after-ai-fueled-d.jpg?locale=us)
UnitedHealth Group Looks Buyable After AI-Fueled Double Beat
The big banks will get the headlines, but investors should watch UnitedHealth Group Inc. (NYSE: UNH). The health insurance giant scored a double beat when it reported fourth-quarter earnings on
![HCA Healthcare Rallies: Weight-loss drugs really a big threat?: https://www.marketbeat.com/logos/articles/med_20240107185912_hca-healthcare-rallies-weight-loss-drugs-really-a.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBMHdFYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--a18c6bc757c70846460135778d82539bb366e6b5/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20240107185912_hca-healthcare-rallies-weight-loss-drugs-really-a.jpg?locale=us)
HCA Healthcare Rallies: Weight-loss drugs really a big threat?
Hospital chain HCA Healthcare, Inc. (NYSE: HCA) has been working on a bullish base and even managed to post gains in a week when the SPDR S&P 500 ETF Trust (NYSEARCA: SPY) pulled back.
Investors
![Neptune Digital Assets Corp. Announces the Release of Audited Financial Statements with a 56% Increase in Mining Revenues and 42% Increase in Digital Currency Balances over Prior Year: https://www.irw-press.at/prcom/images/messages/2023/73124/NDAAnnualFinancialResults_en_PRcom.001.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNGY4YXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--b39757ba33334362ea89c1cd477ae88da217453d/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/NDAAnnualFinancialResults_en_PRcom.001.png?locale=us)
Neptune Digital Assets Corp. Announces the Release of Audited Financial Statements with a 56% Increase in Mining Revenues and 42% Increase in Digital Currency Balances over Prior Year
VANCOUVER, British Columbia – December 28, 2023 – Neptune Digital Assets Corp. (TSX-V:NDA) (OTCQB:NPPTF) (FSE:1NW) (“Neptune” or the "Company"), one of the first publicly traded blockchain
![Neptune Digital Assets Corp. veröffentlicht seinen geprüften Finanzbericht: 56 % Plus bei den Mining-Umsätzen und 42 % Plus beim digitalen Währungsguthaben gegenüber dem Vorjahr: https://www.irw-press.at/prcom/images/messages/2023/73124/NDAAnnualFinancialResults_de_PRcom.001.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNGI4YXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--677baaf54c2c4c677a98702f560ff465fc157a28/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/NDAAnnualFinancialResults_de_PRcom.001.png?locale=us)
Neptune Digital Assets Corp. veröffentlicht seinen geprüften Finanzbericht: 56 % Plus bei den Mining-Umsätzen und 42 % Plus beim digitalen Währungsguthaben gegenüber dem Vorjahr
VANCOUVER, British Columbia – 28. Dezember 2023 / IRW-Press / – Neptune Digital Assets Corp. (TSX-V: NDA) (OTCQB: NPPTF) (FWB: 1NW) („Neptune“ oder das „Unternehmen“), eines der ersten
![Mega merger in the works? Humana, Cigna explore big deal: https://www.marketbeat.com/logos/articles/med_20231201154241_mega-merger-in-the-works-humana-cigna-explore-big.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBOHZsYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--f0e54b22f4366b59a8485b6e113a963b5b9f062a/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20231201154241_mega-merger-in-the-works-humana-cigna-explore-big.jpg?locale=us)
Mega merger in the works? Humana, Cigna explore big deal
Consolidation in the health insurance industry has become a theme of 2023. Humana Inc. (NYSE: HUM) is reportedly in talks to merge with The Cigna Group (NYSE: CI) in a stock-and-cash deal
![BellRing Brands gets pumped on the Ozempic weight-loss trend: https://www.marketbeat.com/logos/articles/med_20231126113844_chart-brbr.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBK0xmYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--d6a8c22f1584e9975545442ba854fc45545ae133/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20231126113844_chart-brbr.jpg?locale=us)
BellRing Brands gets pumped on the Ozempic weight-loss trend
Sports nutritional products maker BellRing Brands Inc. (NYSE: BRBR) has seen its stock surge to new all-time highs driven by the popularity of GLP-1 weight-loss medication usage. While the name of
![J&J stock down as business unit mulls talc-related bankruptcy: https://www.marketbeat.com/logos/articles/med_20231031061438_jj-stock-down-as-business-unit-mulls-talc-related.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNm5DYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--3b4e4009717b3b79d8a100afaaf4d0d826bac35f/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20231031061438_jj-stock-down-as-business-unit-mulls-talc-related.jpg?locale=us)
J&J stock down as business unit mulls talc-related bankruptcy
Shares of Johnson & Johnson (NYSE: JNJ) slid 4.84% lower the week ending October 27, as the company’s subsidiary LTL Management is facing a raft of lawsuits pertaining to talc in its baby powder.
![The Value Deepens for Medtech Stocks: Reversal Imminent: https://www.marketbeat.com/logos/articles/med_20231023085140_chart-bax-10232023ver001.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBeFM1YXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--d1bd08a09883dcaf0726883a8123849ccee19e62/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20231023085140_chart-bax-10232023ver001.png?locale=us)
The Value Deepens for Medtech Stocks: Reversal Imminent
Results from Johnson & Johnson (NYSE: JNJ) and Abbott Laboratories (NYSE: ABT) foreshadow good news for MedTech investors. Both companies outperformed on the top and bottom lines, driven by broad
![Walgreens Boots Alliance: Value or Value Trap?: https://www.marketbeat.com/logos/articles/med_20231012112832_chart-wba-10122023ver001.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBL091YXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--1220828144310370c5f4fd7115ffffe05f2e8bc9/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20231012112832_chart-wba-10122023ver001.png?locale=us)
Walgreens Boots Alliance: Value or Value Trap?
Walgreens Boots Alliance (NASDAQ: WBA) shares are down significantly over the past two years and may fall further. The company's turnaround efforts are slowly taking hold, and the impact of